摘要
近年来,中国在肝脏疾病超声研究领域取得了显著进展,为临床诊断和治疗提供了更加准确和可靠的手段.回顾2023年中国肝脏超声临床研究可以发现:弥漫性肝病的临床研究热点主要为脂肪肝的超声定量评估及超声新技术诊断肝纤维化;局灶性肝病临床研究以肝肿瘤精准诊断及人工智能技术相关应用为主要方向;而肝脏微创介入诊疗领域研究主要涵盖肝肿瘤消融治疗策略优化、消融术后并发症风险评估及预后判断等.2023年肝脏指南与共识等方面的研究成果也将在本文中一并介绍.
Abstract
In recent years,China has made significant progress in the field of liver ultrasound research,providing more accurate and reliable means for clinical diagnosis and treatment.Reviewing the clinical research on liver ultrasound in China in 2023,the hotspots in clinical research on diffuse liver diseases are mainly the quantitative assessment of fatty liver and the diagnosis of liver fibrosis with new ultrasound technologies.The clinical research on focal liver diseases focuses on the precise diagnosis of liver tumors and the related applications of artificial intelligence technology.In the field of diagnosis and treatment of liver disease with minimally invasive interventional ultrasound,it covers the optimization of ablation treatment strategies in liver tumors,the risk assessment of post-ablation complications,and prognosis evaluation,etc.The achievements in the field of liver guidelines and consensus in 2023 will also be introduced in this article.
基金项目
国家自然科学基金(82202173)
上海市卫生健康委员会科研项目(202340087)
复旦大学附属中山医院科技创新基金(2023-2ZSCX19)
NETL
NSTL
万方数据